Vijaya Diagnostic Centre · NSE: VIJAYA · BSE: 543350

Q3 FY25 results · Oct–Dec 2024

Vijaya Diagnostic Centre reported revenue from operations of ₹168.98 crore (up 27.3% from Q3 FY24) and net profit of ₹35.30 crore (up 35.8% from Q3 FY24) for Q3 FY25 (Oct–Dec 2024), on a consolidated basis.

Consolidated · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations168.98132.69+27.3%182.95−7.6%
Other income4.705.11−8.1%4.51+4.1%
Total income173.68137.80+26.0%187.46−7.4%
Profit before tax46.7034.76+34.3%57.19−18.3%
Net profit for the period35.3026.00+35.8%42.12−16.2%
Attributable to shareholders of the company35.1625.85+36.0%41.94−16.2%
EPS, basic (₹)3.422.53+35.2%4.09−16.4%
Net margin (%)20.919.623.0
Standalone · ₹ crore
ItemQ3 FY25Q3 FY24YoYQ2 FY25QoQ
Revenue from operations156.26129.12+21.0%168.61−7.3%
Other income4.995.25−5.0%4.80+3.9%
Total income161.25134.37+20.0%173.41−7.0%
Profit before tax44.3533.84+31.1%53.53−17.2%
Net profit for the period33.5325.25+32.8%39.50−15.1%
EPS, basic (₹)3.262.47+32.0%3.85−15.3%
Net margin (%)21.519.623.4
Consolidated
Filed with BSE
12 Feb 2025, 15:30 IST
Board meeting
12 Feb 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE
Standalone
Filed with BSE
12 Feb 2025, 15:30 IST
Board meeting
12 Feb 2025
Period
01 Oct 2024 to 31 Dec 2024
Review status
Unaudited
Source
XBRL filing on BSE